Figure 3.
The 35-gene signature is independent of tumor stage in lung cancer prognosis. Patients with stage 1A NSCLC from combined cohorts from Bild et al (8), Garber et al (9), and Raponi et al (11) were classified into high- and low-risk groups based on the 35-gene signature in Kaplan-Meier analysis.